Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04826809 · ClinicalTrials.gov registry record · NA
New Reusable Mask Design With Superior Filtration and Fit
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT04826809: Completed NA study, sponsored by Mayo Clinic.
NCT04826809 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04826809, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study will test the filtration, air leak, and breathability of a newly designed fully washable mask developed by Dr. Nordell with the Mayo Clinic. This mask is theorized to be a superior alternative to other respirators currently used when one-time-use N95 masks are unavailable.
Primary Outcome
Number of participants to pass the respirator fit testing using Bitrix solution. If participants do not smell or taste the solution while wearing the respirator it is considered passed.
Interventions
- DEVICE N95 mask
- DEVICE Nordell single E-100 layer mask
- DEVICE Nordell double E-100 layer mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2022-10-27 |
| Phase | NA |
What the finished NCT04826809 record still lists
NCT04826809 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which N95 mask is the first listed.
NCT04826809 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04826809 about?
NCT04826809 is a clinical study titled "New Reusable Mask Design With Superior Filtration and Fit". This study will test the filtration, air leak, and breathability of a newly designed fully washable mask developed by Dr. Nordell with the Mayo Clinic. This mask is theorized to be a superior alternative to other respirators currently used when one-time-use N95 masks are unavailable.
What is the current status of trial NCT04826809?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-04-09. Estimated completion is 2022-10-27.
What interventions are being tested in trial NCT04826809?
The interventions under investigation include: N95 mask (DEVICE), Nordell single E-100 layer mask (DEVICE), Nordell double E-100 layer mask (DEVICE).
Who is sponsoring clinical trial NCT04826809?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04826809's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI